Harmatz, P. Et Al. 2022. Chemically modified recombinant human sulfamidase (SOBI003) in mucopolysaccharidosis IIIA patients: Results from an open, non-controlled, multicenter study. MOLECULAR GENETICS AND METABOLISM , vol.136, no.4 , 249-259.

Harmatz, P., Muenzer, J., EZGÜ, F. S., Dalen, P., Huledal, G., Lindqvist, D., ... Gelius, S. S.(2022). Chemically modified recombinant human sulfamidase (SOBI003) in mucopolysaccharidosis IIIA patients: Results from an open, non-controlled, multicenter study. MOLECULAR GENETICS AND METABOLISM , vol.136, no.4, 249-259.

Harmatz, Paul Et Al. "Chemically modified recombinant human sulfamidase (SOBI003) in mucopolysaccharidosis IIIA patients: Results from an open, non-controlled, multicenter study," MOLECULAR GENETICS AND METABOLISM , vol.136, no.4, 249-259, 2022

Harmatz, Paul Et Al. "Chemically modified recombinant human sulfamidase (SOBI003) in mucopolysaccharidosis IIIA patients: Results from an open, non-controlled, multicenter study." MOLECULAR GENETICS AND METABOLISM , vol.136, no.4, pp.249-259, 2022

Harmatz, P. Et Al. (2022) . "Chemically modified recombinant human sulfamidase (SOBI003) in mucopolysaccharidosis IIIA patients: Results from an open, non-controlled, multicenter study." MOLECULAR GENETICS AND METABOLISM , vol.136, no.4, pp.249-259.

@article{article, author={Paul Harmatz Et Al. }, title={Chemically modified recombinant human sulfamidase (SOBI003) in mucopolysaccharidosis IIIA patients: Results from an open, non-controlled, multicenter study}, journal={MOLECULAR GENETICS AND METABOLISM}, year=2022, pages={249-259} }